Immutep Limited
IMMPNext catalyst
eftilagimod alfa
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Get an email about IMMP's next catalysts
Track Immutep (IMMP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 0 past
eftilagimod alfa Phase 3 Est. Readout
Primary completion for eftilagimod alfa trial (NCT06726265) in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
SourceMarket Overview
Stock performance and key metrics
Immutep Ltd (formerly Prima Biomed) is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech.
Websiteeftilagimod alfa
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
eftilagimod alpha
Breast Carcinoma
cisplatin or carboplatin + pemetrexed
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
IMP321 (eftilagimod alpha)
Adenocarcinoma Breast Stage IV
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
eftilagimod alfa | Phase 3 | Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | - | - |
eftilagimod alpha | Phase 3 | Breast Carcinoma | - | - |
cisplatin or carboplatin + pemetrexed | Phase 3 | Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | - | - |
IMP321 (eftilagimod alpha) | Phase 2 | Adenocarcinoma Breast Stage IV | - | - |
Frequently asked questions
What is in Immutep Limited's drug pipeline?→
CatalystAlert tracks 4 drug candidates in Immutep Limited's (IMMP) pipeline across Phase 3, Phase 2. Its lead program is eftilagimod alfa (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Immutep Limited's next FDA catalyst?→
Immutep Limited's (IMMP) next tracked catalyst is a Phase 3 readout expected June 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track IMMP biotech catalysts?→
Add IMMP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Immutep Limited's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.